Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Prometheus Biosciences, Inc. (RXDX)  
$199.92 0.00 (0.00%) as of 4:30 Thu 6/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 42,478,000
Market Cap: 8.49(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $192.5 - $199.92
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Prometheus Biosciences is a biotechnology company developing a precision medicine approach to the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, starting with inflammatory bowel disease. Co. utilizes its proprietary precision medicine platform, Prometheus360™, which includes a gastrointestinal bioinformatics database and sample biobank, to identify therapeutic targets and develop therapeutic candidates to engage those targets. In parallel, Co. is developing companion diagnostic tests designed to identify patients more likely to respond to our therapeutic candidates.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 1,020,000
Total Sell Value $0 $0 $0 $117,606,181
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 12
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 17
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Cedars Sinai Intellectual Property Co 10% Owner   –       –       •   2021-06-25 3 IO $0.00 $0 I/I 0 5,008,508 55%     
   Cormorant Private Healthcare Fund Iii Lp Former 10% Owner   –       –      –    2021-03-16 4 B $19.00 $7,125,000 I/I 375,000 2,223,022 0.01 -6%     
   Cormorant Private Healthcare Fund Iii Lp Former 10% Owner   –       –      –    2021-03-16 4 A $0.00 $0 I/I 1,848,022 1,848,022     -
   Cohen Steven A/sac Capital Mgmt Lp Former 10% Owner   –       –      –    2021-03-16 4 B $19.00 $15,200,000 I/I 800,000 2,648,024 0.01 -6%     
   Cohen Steven A/sac Capital Mgmt Lp Former 10% Owner   –       –      –    2021-03-16 4 A $0.00 $0 I/I 1,848,024 1,848,024     -
   Cedars Sinai Medical Center 10% Owner   –       –       •   2021-03-16 4 A $0.00 $0 D/D 4,416,008 5,008,508     -
   Yamada Tadataka and Chairman of the Board   –       •      –    2021-03-16 4 A $0.00 $0 D/D 13,333 13,333     -
   Papa Joseph C Director   –       •      –    2021-03-16 4 B $19.00 $285,000 D/D 15,000 15,000 2.39 -6%     
   Stenhouse Mark Chief Operating Officer   •       –      –    2021-03-16 4 B $19.00 $266,000 D/D 14,000 14,000 2.74 -6%     
   Adams Helen C. Director   –       •      –    2021-03-16 4 B $19.00 $9,500 D/D 500 500 2.39 -6%     
   Wong Roderick 10% Owner   –       –       •   2021-03-16 4 A $0.00 $0 I/I 2,464,031 3,264,031     -
   Wong Roderick 10% Owner   –       –       •   2021-03-16 4 B $19.00 $15,200,000 I/I 800,000 800,000 1.5 -6%     
   Edelman Joseph 10% Owner   –       –       •   2021-03-16 4 B $19.00 $16,150,000 I/I 850,000 3,314,032 1.5 -6%     
   Edelman Joseph 10% Owner   –       –       •   2021-03-16 4 A $0.00 $0 I/I 2,464,032 2,464,032     -
   Luo Allison Chief Medical OfficerOfficer   •       –      –    2021-03-11 3 IO $0.00 $0 I/I 0 67,708     -
   Luo Allison Chief Medical OfficerOfficer   •       –      –    2021-03-11 3 IO $0.00 $0 D/D 0 50,000     -
   Cedars Sinai Medical Center 10% Owner   –       –       •   2021-03-11 3 IO $0.00 $0 D/D 0 592,500     -

  17 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed